Rabeprazole Sodium (Mylan Pharmaceuticals Inc.)
Welcome to the PulseAid listing for the Rabeprazole Sodium drug offered from Mylan Pharmaceuticals Inc.. This Proton Pump Inhibitor [EPC],Proton Pump Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Mylan Pharmaceuticals Inc. |
| NON-PROPRIETARY NAME: | rabeprazole |
| SUBSTANCE NAME: | RABEPRAZOLE SODIUM |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Proton Pump Inhibitor [EPC],Proton Pump Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, DELAYED RELEASE |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2013-11-08 |
| END MARKETING DATE: | 0000-00-00 |
Rabeprazole Sodium HUMAN PRESCRIPTION DRUG Details:
| Item Description | Rabeprazole Sodium from Mylan Pharmaceuticals Inc. |
| LABELER NAME: | Mylan Pharmaceuticals Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 20(mg/1) |
| START MARKETING DATE: | 2013-11-08 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0378-6709_470eca6b-3701-4a9b-97f3-abdee3226d12 |
| PRODUCT NDC: | 0378-6709 |
| APPLICATION NUMBER: | ANDA076885 |
Other RABEPRAZOLE SODIUM Pharmaceutical Manufacturers / Labelers:
